Ameet Mallik

CIK: 0001861441

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)4 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

ADCT

ADC Therapeutics SA

DirectorOfficer

ATRA

Atara Biotherapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (8 total)

ADCT
ADC Therapeutics SA
Jun 30, 2026
Award(A)
Direct
675K shares-
ADCT
ADC Therapeutics SA
Feb 13, 2026
Tax Payment(F)
Direct
103.2K shares at avg. $3.99$412K
ADCT
ADC Therapeutics SA
Feb 13, 2026
Award(A)
Direct
900K shares at avg. $3.99$3.6M
ADCT
ADC Therapeutics SA
Dec 6, 2025
Tax Payment(F)
Direct
233.1K shares at avg. $3.29$767K
ATRA
Atara Biotherapeutics, Inc.
Jun 10, 2025
Award(A)
Direct
7.8K shares-
ADCT
ADC Therapeutics SA
May 6, 2025
Tax Payment(F)
Direct
26.8K shares at avg. $1.29$35K
ADCT
ADC Therapeutics SA
Feb 13, 2025
Award(A)
Direct
650K shares at avg. $1.61$1.0M
ADCT
ADC Therapeutics SA
Dec 6, 2024
Tax Payment(F)
Direct
238.3K shares at avg. $3.13$746K

		Type	Shares	Price		Ownership
Jun 30, 2026	ADCT ADC Therapeutics SA	Award(A)	675,000	-	$0	Direct
Feb 13, 2026	ADCT ADC Therapeutics SA	Tax Payment(F)	103,231	$3.99	$411,892	Direct
Feb 13, 2026	ADCT ADC Therapeutics SA	Award(A)	900,000	$3.99	$3,591,000	Direct
Dec 6, 2025	ADCT ADC Therapeutics SA	Tax Payment(F)	233,146	$3.29	$767,050	Direct
Jun 10, 2025	ATRA Atara Biotherapeutics, Inc.	Award(A)	7,828	-	-	Direct
May 6, 2025	ADCT ADC Therapeutics SA	Tax Payment(F)	26,758	$1.29	$34,518	Direct
Feb 13, 2025	ADCT ADC Therapeutics SA	Award(A)	650,000	$1.61	$1,046,500	Direct
Dec 6, 2024	ADCT ADC Therapeutics SA	Tax Payment(F)	238,343	$3.13	$746,014	Direct

1-8 of 8 transactions

About MALLIK AMEET

MALLIK AMEET (SEC CIK 0001861441) files insider reports with the SEC as Chief Executive Officer of ADC Therapeutics SA (ADCT) and Director of Atara Biotherapeutics, Inc. (ATRA).

Signal8 holds 7 ownership filings by MALLIK AMEET, all Form 4s, filed between Dec 9, 2024 and Jul 2, 2026. Those filings report 8 transactions, from Dec 6, 2024 to Jun 30, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on MALLIK AMEET's filings is in NEW PROVIDENCE, NJ.

Recent filings by MALLIK AMEET

Jun 30, 2026: Grant or award of ADCT shares (Form 4, code A).
Feb 13, 2026: Tax withholding of ADCT shares (Form 4, code F).
Feb 13, 2026: Grant or award of ADCT shares (Form 4, code A).
Dec 6, 2025: Tax withholding of ADCT shares (Form 4, code F).
Jun 10, 2025: Grant or award of ATRA shares (Form 4, code A).

Other insiders filing for ADC Therapeutics SA (ADCT)

Zaki Mohamed, Chief Medical Officer
GRAHAM PETER J, Chief Legal Officer
Carmona Jose, Chief Financial Officer
Azelby Robert, Director
Squarer Ron, Director
Sandor Victor, Director

How to read Form 4 transaction codes